Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy

scientific article published in September 2001

Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10428190109097710
P698PubMed publication ID11697646

P2093author name stringFlexner JM
Greer JP
Stein RS
Goodman S
McCurley TL
Wolff SN
Brandt SJ
Morgan DS
Arrowsmith E
Jagasia M
P2860cites workNonparametric Estimation from Incomplete ObservationsQ25938997
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group BQ28247684
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remissionQ28290182
The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemiaQ40797444
P433issue5
P921main subjectcytarabineQ180983
cytogeneticsQ246128
daunorubicinQ411659
P304page(s)913-922
P577publication date2001-09-01
P1433published inLeukemia & LymphomaQ6534493
P1476titleAge and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy
P478volume42

Search more.